THY1 and cancer: In the present study, CD90 was used as a possible marker for LCSC-like cells, and these LCSC-like cells were isolated from liver cancer cells HepG2, and changes in the expression of miRNAs, cancer-inhibiting genes and apoptosis-related genes were determined.